Deep Dive: Market Access

Market Access
Chess board with man pushing piece Deep Dive Market Access

Deep Dive: Market Access 2024

In this edition of Deep Dive, Unpacking complex choreography in the biologics patent dance, Alexion examines the urgent need for accelerated access programmes for rare disease treatments, and Putna

Market Access
Addressing Europe’s plasma deficit

Addressing Europe’s plasma deficit

Across the European Union approximately 300,000 patients with chronic conditions, such as haemophilia and severe immune-deficiency, depend on plasma-derived medicines, which can only be man

Market Access
12 questions with: Daniel Kohlstaedt

12 questions with: Daniel Kohlstaedt

Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry.